Healthcare - Biotechnology - NASDAQ - GB
$ 1.065
0.472 %
$ 37.4 M
Market Cap
-1.87
P/E
CASH FLOW STATEMENT
-9.49 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
6.21 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
OKYO Pharma Limited
| Net Income | -16.8 M |
| Depreciation & Amortization | 3.87 K |
| Capital Expenditures | -3 |
| Stock-Based Compensation | 1.12 M |
| Change in Working Capital | 2.67 M |
| Others | 2.95 M |
| Free Cash Flow | -9.49 M |
Cash Flow
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 | Mar-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||
| Net Income | (16.8) | (13.3) | (6.2) | (3.4) | (1.6) | (4.9) | (28.3) | (0.2) | (0.8) | (8.3) | (13.9) | (4.7) | (5.7) | (1.8) | 12.7 | 14.0 | (3.3) |
| Depreciation & Amortization | 3.87 K | 3.8 K | 2.33 K | 13.1 K | 5.98 K | 218 | 0 | 0 | 0 | 0 | 0.1 | 24.4 K | 19.6 K | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0.3 | 9.41 K | 92.9 K | 0.1 | 1.17 K | 0 | 0 | 0 | 0 | 9.0 | 0.000001 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.1 | 1.3 | 1.7 | 0.5 | 36.3 K | 50.5 K | 4.24 K | 18.4 K | 99.2 K | 0 | 1.4 | 1.3 | 0.8 | 0.2 | 0.2 | 0.1 | 2.4 |
| Other Operating Activities | 3.5 | 0.1 | 61.7 K | 83 K | 42.8 K | 2.7 | 26.6 | 0.000001 | 39.3 K | 6.9 | 9.0 | 93.2 K | 20.7 K | 0.3 | (13.7) | (14.3) | 0.3 |
| Change in Working Capital | 2.7 | 3.9 | (1.0) | 1.0 | 0.2 | 0.2 | 35.7 K | (0.4) | 0.1 | 74.7 K | 55.6 K | (0.4) | 0.2 | 17.7 K | 7.54 K | 22.9 K | 75.4 K |
| Cash From Operations | (9.5) | (7.7) | (5.5) | (1.6) | (1.2) | (2.0) | (1.6) | (0.7) | (0.7) | (1.4) | (3.5) | (3.8) | (4.7) | (1.3) | (0.9) | (0.2) | (0.5) |
| INVESTING CASH FLOW | |||||||||||||||||
| Capital Expenditures | 3 | 5.92 K | 1.67 K | 6.94 K | 0 | 1.32 K | 0 | (0.4) | (0.4) | (2.8) | (10.6) | (7.2) | (3.5) | 0 | 0 | (0.7) | (2.8) |
| Other Items | 3 | 0 | 0 | 11.2 K | (0.1) | 0 | 0 | 0 | 70.9 K | 0 | 53 K | 0 | (0.6) | 29.1 | 20.8 | (10.6) | 0 |
| Cash From Investing Activities | 0 | 5.92 K | 1.67 K | 18.1 K | (0.1) | 1.32 K | 0 | (0.4) | (0.3) | (2.8) | (10.6) | (7.2) | (4.1) | 29.1 | 20.8 | (11.3) | (2.8) |
| FINANCING CASH FLOW | |||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 2.0 | 0 | 7.6 | 0 | 0 | 0 | 4.42 K | 12.4 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (40.7) | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 2.2 | 15.9 K | 27.3 K | 0 | 0 | 0 | 0 | 0.1 | 0.2 | 0.2 | 0.8 | 0.722 | 0 | 0 | 0 |
| Cash From Financing Activities | 6.2 | 9.3 | 2.2 | 7.8 | 1.0 | 0 | 0 | 4.42 K | 12.4 K | 0.4 | 10.4 | 8.7 | 9.3 | (40.2) | 1.0 | 3.9 | 21.3 |
| CHANGE IN CASH | |||||||||||||||||
| Net Change In Cash | (3.2) | 1.3 | (4.2) | 6.7 | (0.4) | (2.0) | (1.6) | (0.7) | (1.1) | (4.1) | (3.9) | (1.8) | 1.0 | (12.3) | 21.0 | (7.6) | 18.0 |
| FREE CASH FLOW | |||||||||||||||||
| Free Cash Flow | (9.5) | (7.7) | (5.5) | (1.6) | (1.2) | (2.0) | (1.6) | (1.0) | (1.1) | (4.2) | (14.1) | (11.0) | (8.2) | (1.3) | (0.9) | (0.9) | (3.3) |